Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the effects of Cetyl Tranexamate Mesylate on acne-related hyperpigmentation through a specific delivery form known as TeraCeutic TXVector.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Integrative Skin Science and Research
Collaborators
NCT03465150 · Acne
NCT05639933 · Acneiform Eruption Due to Chemical, Xerosis Cutis, and more
NCT07058883 · Acne Scars
NCT07406893 · Joint Arthroplasty, Shoulder, and more
NCT07368764 · Acne, Acne Scars
Integrative Skin and Research
Sacramento, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions